Sascha Schreiber
Paris-trained, Los Angeles-based beauty and fragrance product development executive with 8+ years across major beauty groups including L'Oréal and Estée Lauder, as well as niche fragrance houses such as Éditions de Parfums Frédéric Malle and Balmain Beauty — with products featured in Vogue, Harper's Bazaar and Forbes among other publications, and industry recognition through the Fragrance Foundation and Marie Claire Awards.
The future of fragrance, beauty and wellness belongs to brands that treat product as their greatest creative expression — and their strongest competitive advantage. I partner with founders and brands at the intersection of creative ambition and technical execution — turning vision into product, and building the systems designed for scale while preserving agility, creative autonomy and speed to market.
Established supplier, fragrance house and manufacturing relationships across the United States and Europe.
Available on a consulting or fractional basis.
Shape the opportunity, portfolio and product proposition.
Translate the idea into a technically and commercially viable product.
Design the systems, supplier network and operating model required for growth.
Led product development of the Acne Studios x Frédéric Malle collaboration, generating €6.5M+ annualized commercial value, contributing approximately 10% of annual brand revenue, and driving 75% new customer acquisition.
Worked alongside founders and brand teams to keep niche brands recognizably themselves inside a global group — building the product-development operating model, governance and cross-functional processes that let a 300+ SKU portfolio representing €110M+ in annual revenue scale without surrendering brand autonomy, creative intention, product integrity or speed to market.
Across 130+ innovation and business-continuity initiatives, the work spanned new-product development, formulation, quality, manufacturing, supplier management and launch governance — connecting creative teams with the technical and operational infrastructure needed to execute without significant trade-offs at scale. Redesigned approval and evaluation workflows cut internal evaluation workload by 90%.
